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Introduction
Congenital anomalies of the kidney and urinary tract (CAKUT) comprise a wide range of structural malformations that result from defects in the morphogenesis of the kidney and/or the urinary tract. These anomalies include among others: renal agenesis, renal hypodysplasia, multicystic dysplastic kidney, hydronephrosis, ureteropelvic junction obstruction, megaureter, ureter duplex, vesicoureteral reflux, and posterior urethral valves [1] . CAKUT account for about 40-50 % of children with chronic kidney disease [2] . The condition may appear as an isolated feature or as part of a systemic condition that encompasses extra-renal manifestations [3] [4] [5] . The notion that CAKUT may be caused by single-gene mutations ("monogenic CAKUT") is suggested by three findings: (1) CAKUT may appear with familial aggregation [6] ; (2) monogenic mouse models exhibit CAKUT phenotypes; (3) human multi-organ monogenic syndromes may include CAKUT phenotypes. Recently this notion was corroborated by the discovery of more than 20 single-gene causes for CAKUT in humans [7] [8] [9] [10] [11] . Until then, only a handful of CAKUT-causing genes had been documented, most of which were identified among familial syndromic cases, including HNF1B (renal cysts and diabetes syndrome) [4] , PAX2 (renal coloboma syndrome) [3] , and EYA1 (branchio-oto-renal syndrome) [5] . Recent findings suggest that CAKUT may be caused by a multitude of different disease-causing genes (Table 1) , each gene representing a monogenic recessive or dominant cause of CAKUT [3] [4] [5] . Given this broad genetic locus heterogeneity and the rapidly evolving sequencing technology, it is likely that many novel genes will be identified in the near future.
We focus here on single-gene causes of CAKUT and their developmental mechanisms. We mainly discus diseasecausing genes related to isolated CAKUT or syndromic forms of CAKUT in which the renal phenotype predominates. Single-gene causes of human congenital urinary bladder diseases are beyond the scope of this review and have been recently reviewed [37] .
CAKUTare due to disordered genetic control of kidney development
The pathology of CAKUT is based on the disturbance of normal nephrogenesis, and can be due to genetic abnormalities in renal developmental genes that direct this process [1, [38] [39] [40] [41] . In order to understand the genetic basis of human CAKUT, it is essential to consider how the normal kidney develops (Fig. 1 ). Kidney development can be divided into the following developmental stages: ureteric bud induction, mesenchymal-toepithelial transition (MET), renal branching morphogenesis, and nephron patterning and elongation (which include proximal and distal tubule morphogenesis and glomerulogenesis) [1, [38] [39] [40] [41] . The underlying molecular control of these developmental stages is governed by a large number of genes and signaling pathways that orchestrate this complex process. Perturbation in each of these steps, as supported by mouse models, can lead to the clinical phenotype of CAKUT. Insights into the related molecular control mechanisms has led to a paradigm shift away from classic anatomic theories to contemporary cell biological and genetic views of the etiology of CAKUT [42] . For many years, mouse models have been a key tool in our understanding of the molecular basis of kidney development with numerous mouse models re-capitulating human disease phenotypes. For instance, in mice, the following monogenic causes of CAKUT have been described for the following process: (1) Ret and Gdnf for ureteric bud induction [43] , (2) Wnt4 for mesenchymal-toepithelial transition (MET) [44] , and (3) Agtr2 (Angiotensin receptor 2) for branching morphogenesis [45] . Figure 1 outlines key steps during normal kidney development and their corresponding CAKUT-causing genes in mice and humans.
Classical studies [46] have also highlighted the importance of the position of the ureteric budding in the development of CAKUT and lead to the "budding hypothesis". According to this hypothesis, the precise position at which the ureteric bud grows out from the mesonephric duct is critical for subsequent normal kidney and urinary tract development. This hypothesis was generated following the anatomical analysis of duplex kidneys, which showed that a more severe hypoplasia and dysplasia were closely correlated with mal-displacement of the ureteral orifice. This hypothesis, in part, is supported by the fact that many "early development" genes, involved in the The products of most genes that if mutated cause CAKUT in humans are involved in the control of the early morphogenesis stages of the kidney, i.e., induction of the metanephric mesenchyme by the ureteric bud and mesenchymal-to-epithelial transition. Ureteric budding is promoted by GDNF signaling via its receptor RET. In humans, mutations in RET were initially recognized to cause multiple endocrine neoplasia (MEN) syndrome [47] and Hirschsprung's disease [48] . RET mutations were subsequently reported to cause CAKUT in fetuses with bilateral renal hypodysplasia/agenesis [18, 49] . In addition, the role of RET as a CAKUT-causing gene is suggested by the finding that many patients with Hirschsprung's disease have silent urinary tract defects [50] . Still, data regarding the frequency of RET as a CAKUT-causing gene are conflicting [18, 49] . Mutation analysis of GDNF has been performed in patients with CAKUT. However, no evidence supporting its causative role has been established so far [30, 51] . The GDNF-RET signaling pathway is regulated by multiple circuits. Given the central role of the GDNF-RET signaling pathway in ureteric budding, it was likely that mutations in genes that regulate this pathway may result in CAKUT. Indeed, these regulatory mechanisms include transcription factors such as PAX2, EYA1, and SALL1, all of which have been initially recognized to be mutated in small pedigrees with multiple affected individuals with CAKUT and syndromespecific extra-renal manifestations. Mutations in PAX2 were first identified in patients with renal coloboma syndrome, which comprises renal hypodysplasia, optic nerve abnormalities, and deafness [3] . To date, more than 55 disease-causing mutations of PAX2 have been reported worldwide [17] . Importantly, PAX2 mutations were shown to also lead to isolated CAKUT without optic nerve or hearing abnormalities or with subtle features. In addition, PAX2-mutations were shown to lead to variable renal phenotypes across the spectrum of CAKUT, including renal hypodysplasia, vesicoureteral reflux renal cysts, and multicystic dysplastic kidneys as the most common ones [17] . Mutations in EYA1 lead to branchio-oto-renal (BOR) syndrome, which is characterized by hearing loss, structural defects of the ear, branchial fistula or cyst, and CAKUT, ranging from mild renal hypoplasia to agenesis [5] . Interestingly, mutations in SIX1 and SIX5 have also been identified in patients with EYA1-negative BOR syndrome, and probably represent a more rare underlying etiology [22, 23] . Mutations in SALL1 lead to Townes-Brocks syndrome (TBS), which is characterized by kidney, anal, ear, and thumb abnormalities [21] . An isolated CAKUT phenotype was reported in one patient with a SALL1 mutation [52] . Unpublished data from our lab further support an isolated CAKUT phenotype. BMP4 is expressed in the mesenchymal cells that surround the Wolffian duct and inhibits GDNF-RET-signaling [38] . Missense mutations in BMP4 were identified in five CAKUT patients [12] . Subsequent functional analysis, using overexpression assays in zebrafish suggested that these mutations affect BMP4 protein function [53] .
Human CAKUT-causing genes involved in mesenchymal-to-epithelial transition
Once the ureteric bud invades the metanephrogenic mesenchyme, it induces condensation of the metanephrogenic mesenchymal cells around the ureteric bud tips. This step begins the polarization of the mesenchyme to generate the epithelial cells of the nephron in a process named mesenchymal-to-epithelial transition (MET) [38, 39] . WNT proteins, i.e., WNT9b and WNT4, which act within the WNT signaling pathway, play a critical role in this process [38, 39] . Furthermore, recent evidence generated from mouse models supports that the WNT-pathway is partially regulated by SIX2 [54] . Interestingly, mutations in WNT4 or SIX2 have been identified in pediatric patients with CAKUT [12, 30] . Other important key players in MET are the fibroblast growth factor (FGF) ligands Fgf8 and Fgf9 (Fig. 1) [38, 39] . In addition, in a recent report, on three affected fetuses with bilateral renal agenesis from a consanguineous family, an autosomal recessive loss of function mutation gene was identified in the FGF20 [36] .
Human CAKUT-causing genes involved in branching morphogenesis
Renal branching morphogenesis follows the primary ureteric bud outgrowth. The ureteric bud subsequently undergoes serial branching to generate approximately 15 generations of branches. During this time, new nephrons are induced at the tip of each branching bud (Fig. 1) . Several factors have been shown to modulate the UB branching morphogenesis [39] . One of the Fig. 1 Mechanisms of kidney development and corresponding congenital anomalies of the kidney and urinary tract (CAKUT)-causing genes in mice and humans. Steps of nephrogenesis (left column, a to d) and the corresponding CAKUT-causing genes in mice (orange column) and human (right yellow column). The kidney is formed via reciprocal induction between the ureteric bud (UB) and the metanephric mesenchyme (MM) (a). The UB invades the MM cells, which in turn condense around the tip of the branching UB (pre-tubular aggregate). Polarized renal vesicles subsequently develop in mesenchyme-to-epithelial transition (MET) (b). The cells sequentially form comma-shaped and S-shaped bodies and finally give rise to the mature nephron segments (distal and proximal tubule, loop of Henle, and glomerulus) (d). At the same time, the ureteric bud branches in a highly reproducible manner and nephrons are induced at each ureteric bud tip (c). These branches eventually form the collecting system, including collecting ducts, renal pelvis, ureter, and bladder trigone. WD Wolffian duct; UB ureteric bud; MM metanephrogenic mesenchyme; CD collecting duct; DT distal tubule; PT proximal tubule factors that govern this process is Angiotensin 2. Angiotensin 2 activates both the angiotensin receptor type 1 and 2 on the ureteric bud to stimulate branching. In addition, it is required for elongation of the collecting duct [39] . Accordingly, mutations in the genes encoding several components of the reninangiotensin system: AGT (angiotensinogen), REN (renin), ACE (angiotensin-converting enzyme), and AGTR1 (angiotensin II receptor type 1) have been linked to the distinct severe phenotype of CAKUT in humans of renal tubular dysgenesis [34] ( Table 1) . This rare fetal autosomal recessive disorder is characterized by early onset of persistent anuria leading to oligohydramnios and the Potter sequence, secondary to the absence or incomplete differentiation of the proximal tubules. Inactivation of different components of the RAS has been performed in mice. While Agtr2 [45] and Agt [55] null mice have CAKUT, this phenotype was not recapitulated in Ace and Ren null mice. These findings illustrate the possible discrepancies between mouse models and human diseases whereas the former exhibit an earlier developmental insult (branching morphogenesis) as compared to the later insult (developmental abnormality of the proximal tubules due to impaired tubular growth and differentiation).
Human CAKUT-causing genes involved in nephron patterning and elongation
Whereas a large amount of research has focused on the initial stages of kidney formation, much less is known about the genetic programs that drive segmentation of the nephron [41] . Indeed, the only possible human CAKUT-causing gene that can be designated under this category is UMOD. The Uromodulin (UMOD) gene encodes the Tamm-Horsfall protein, which is the most abundant urinary protein in humans [56] . UMOD mutations cause a large variety of different kidney syndromes: (1) medullary cystic kidney disease type 2 (MCKD2), (2) familial juvenile hyperuricemic nephropathy (FJHN), and (3) glomerulocystic kidney disease (GCKD) [33] . All of these disorders are inherited in an autosomal dominant mode and may have a CAKUT phenotype. Nevertheless, in a previous study published by our group, no UMOD mutations were identified among 96 patients with isolated CAKUT, implying that it may represent a very rare etiology for this condition [57] .
Human CAKUT-causing genes yet unassigned to a specific developmental stage
The developmental role of some human CAKUT-causing genes is still poorly understood. In this respect, we will discuss two important genes, HNF1B and DSTYK. Hepatocyte nuclear factor 1B (HNF1B) is a homeodomain-containing transcription factor. HNF1B is an essential factor for embryogenesis of the kidney, pancreas, and liver, and is expressed in the Wolffian duct from a very early developmental stage of the kidney [58] . Mutations in HNF1B have originally been recognized as the cause of the renal cysts and diabetes syndrome (RCDS) [4] . Subsequently, HNF1B mutations and deletions were reported among individuals with isolated CAKUT encompassing different renal malformations across its spectrum, such as renal hypodysplasia, multicystic dysplastic kidney, cystic kidney disease, single kidney, and oligomeganephronia [52, 59] . HNF1B mutations have also been recognized to result in genital tract abnormalities, elevated liver function tests, hyperuricemia [60] , and hypomagnesemia [61] . Interestingly, several recent publications showed that contiguous gene deletion in the 17q12 region (which includes the HNF1B transcription factor) has resulted in the clinical combination of autism/schizophrenia and CAKUT [62, 63] .
With regard to pathomechanism, a link was identified between HNF1B mutations and autosomal recessive polycystic kidney disease (ARPKD), which is caused by mutations in PKHD1 (polycystic kidney and hepatic disease 1). In mice, it has been shown that Hnf1b binds specifically to the Pkhd1 promoter and stimulates gene transcription. Since Hnf1b directly regulates the transcription of Pkhd1, mutations in HNF1B can inhibit PKHD1 gene expression and therefore may contribute to the formation of renal cysts in humans with RCDS [64] .
Currently, HNF1B and PAX2 are considered to be the most frequent CAKUT-causing genes. Still, they are responsible for not more than 5-15 % of cases depending on the examined cohort [52, 65, 66] .
In a recent study involving seven affected family members with CAKUT, disease-causing mutations were detected in the gene DSTYK [32] . Additional DSTYK mutations were detected in seven out of 311 (2.3 %) unrelated patients with CAKUT. The study demonstrated that DSTYK is a positive regulator of ERK phosphorylation downstream of FGF-receptor activation during kidney development [32] .
Finally, another aspect of CAKUT that should be taken into consideration with regard to gene discovery is copy number variations (CNVs). Several lines of evidence support their role in CAKUT [67] . This concept has been highlighted recently in a study involving 522 patients with CAKUT in which 72 distinct known or novel copy-number variations in 87 (16.6 %) patients were identified, suggesting that kidney malformations can, in part, result from pathogenic genomic imbalances [68] .
Conclusions and future directions
CAKUT are a genetically heterogeneous group of disorders that are caused by mutations in genes involved in the embryogenesis of the kidneys. The malformation phenotypes due to the altered proteins vary from normally appearing kidneys with intact kidney function (i.e., incomplete penetrance) to severe hypodysplasia and end-stage kidney disease. In clinical practice, the evaluation of patients with CAKUT, in addition to standard care, should include: (1) meticulous evaluation for extra-renal syndrome-specific signs and symptoms (see Table 1 ); (2) thorough family evaluation for the presence of CAKUT in other family members; (3) referral to genetic counseling. Currently, the most common CAKUT-causing genes are HNF1B and PAX2. Other cases, which often present sporadically, are probably the result of many rare diseasecausing genes.
Novel gene discovery for CAKUT is hampered by a high degree of sporadic cases, genetic heterogeneity, lack of genotype-phenotype correlation, and phenotypic heterogeneity. For example, single-gene causes of primary VUR are still elusive despite the fact that multiple disease loci were published [69] . Although primary VUR is one of the most commonly detected CAKUT presentations, its phenotypic case ascertainment is challenging. The fact that improved prenatal ultrasound examinations have resulted in the recognition that often VUR is accompanied by concomitant other congenital kidney and urinary tract abnormalities can provide one explanation for that. However, the advent and progress in sequencing and bioinformatics technologies should ensure that additional CAKUT-causing genes will be described in the near future. This may lead to more relevant etiologic categorization of disease entities than can be provided by ultrasound imaging or histopathology alone. Such assignments may have prognostic implications for patients with CAKUT.
